Concord Biotech Limited (NSE:CONCORDBIO)
India
· Delayed Price · Currency is INR 1,134.50
+62.50 (5.83%)
Apr 29, 2026, 3:30 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 112.15 billion as of April 29, 2026. Its market cap has decreased by -35.29% in one year.
Market Cap
112.15B
Enterprise Value
108.84B
Revenue
11.59B
Ranking
n/a
PE Ratio
36.11
Stock Price
1,134.50
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 112.15B, an increase of 13.70%. That is a compound annual growth rate of 4.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 112.15B | -20.33% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Blue Jet Healthcare | 76.96B |
| OneSource Specialty Pharma | 209.96B |
| Supriya Lifescience | 56.70B |
| Zota Health Care | 44.49B |
| Anthem Biosciences | 432.30B |
| Dishman Carbogen Amcis | 27.41B |
| Panacea Biotec | 22.59B |
| Biocon | 585.85B |